Back to Search
Start Over
Phenotypic Labelling Using Drug-Induced Sleep Endoscopy Improves Patient Selection for Mandibular Advancement Device Outcome: A Prospective Study
- Source :
- Journal of clinical sleep medicine
- Publication Year :
- 2019
-
Abstract
- Mandibular advancement device (MAD) outcome varies between patients. We hypothesized that upper airway collapse sites, patterns, and degrees assessed during baseline drug-induced sleep endoscopy (DISE) affect MAD outcome.One hundred patients with obstructive sleep apnea (OSA) were included and underwent baseline type 1 polysomnography. MAD was fitted intraorally at fixed 75% maximal protrusion. A total of 72 patients completed 3-month follow-up polysomnography and baseline DISE. Response was defined as apnea-hypopnea index (AHI) reduction ≥ 50%, deterioration as AHI increases during MAD treatment compared to baseline.Adjusting for baseline AHI and body mass index, patients with tongue base collapse showed 3.69 higher odds (1.27-10.73; P = .0128) for response. Complete concentric collapse at the level of the palate (5.32 [1.21-23.28]; P = .0234) and complete laterolateral oropharyngeal collapse (6.62 [1.14-38.34]; P = .0330) related to deterioration. Results for tongue base collapse and complete concentric collapse at the level of the palate were confirmed in the moderate to severe OSA subgroup. Applying these results to this selected subgroup increased response rate with 54% and decreased deterioration rate with 53%. These results were confirmed using other response and deterioration definitions.Three baseline DISE phenotypes identified during drug-induced sleep were significantly related to MAD treatment outcome: one beneficial, tongue base collapse, and two adverse, complete concentric collapse at the level of the palate and complete laterolateral oropharyngeal collapse. If confirmed in future prospective studies, these results could guide patient selection for MAD outcome.This prospective clinical trial (PROMAD) was registered on Clinicaltrials.gov with identifier: NCT01532050.Op de Beeck S, Dieltjens M, Verbruggen AE, Vroegop AV, Wouters K, Hamans E, Willemen M, Verbraecken J, De Backer WA, Van de Heyning PH, Braem MJ, Vanderveken OM. Phenotypic labelling using drug-induced sleep endoscopy improves patient selection for mandibular advancement device outcome: a prospective study. J Clin Sleep Med. 2019;15(8):1089-1099.
- Subjects :
- Pulmonary and Respiratory Medicine
Drug
Male
medicine.medical_specialty
animal structures
media_common.quotation_subject
Polysomnography
03 medical and health sciences
0302 clinical medicine
Tongue
Internal medicine
medicine
Humans
Hypnotics and Sedatives
Prospective Studies
Prospective cohort study
Selection (genetic algorithm)
media_common
Sleep Apnea, Obstructive
business.industry
Endoscopy
Occlusal Splints
Middle Aged
medicine.disease
Obstructive sleep apnea
Treatment Outcome
Neurology
Sleep endoscopy
Female
Human medicine
Neurology (clinical)
Personalized medicine
Airway
business
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 15509397 and 15509389
- Volume :
- 15
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
- Accession number :
- edsair.doi.dedup.....751a7a94518a35ee8be6024e4764d8ea